Hypoglycemic activity of Ailanthus excelsa leaves in normal and streptozotocin-induced diabetic rats

Phytotherapy Research

Volumn 22, Issue 3, 2008, Pages 303-307

  Cabrera, W ^a   Genta, S ^a   Said, A ^b   Farag, A ^c   Rashed, K ^b   Sánchez, Sara S ^a,d  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

^b NATIONAL RESEARCH CENTRE   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d NONE   (Argentina)

Author keywords

Ailanthus excelsa; Hypoglycemic effect; Streptozotocin induced diabetes

Indexed keywords

AILANTHUS EXCELSA EXTRACT; GLYMEPIRIDE; PLANT EXTRACT; UNCLASSIFIED DRUG;

AILANTHUS EXCELSA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOGLYCEMIA; KIDNEY FUNCTION; MALE; MEDICINAL PLANT; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PLANT LEAF; POSTPRANDIAL STATE; RAT; STREPTOZOCIN DIABETES;

AILANTHUS; ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPOGLYCEMIC AGENTS; INSULIN; MALE; METHANOL; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; RATS; RATS, WISTAR; SULFONYLUREA COMPOUNDS; TIME FACTORS;

AILANTHUS; ANIMALIA; RATTUS; SIMAROUBACEAE;

EID: 40849106496     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2311     Document Type: Article

References (25)

1. Adamik K, Brauns FE. 1957. Ailanthus glendulosa (Tree-of-heaven) as a pulpwood. Tappi 40: 522-527.
2. Almdal TP, Vilstrup H. 1988. Strict insulin treatment normalizes the organic nitrogen contents and the capacity of urea-N synthesis in experimental diabetes in rats. Diabetologia 31: 114-118.
3. Asolkar LV, Kakkar KK, Chakre OJ. 1992. Glossary of Indian Medicinal Plant with Active Principles. Part I. CSIR: New Delhi, 34.
4. Bailey CJ, Day C, Turner SL, Leaterdhale BA. 1985. Cerasse, a traditional treatment for diabetes, studies in normal and streptozotocin diabetic mice. Diabetes Res 2: 81-84.
5. British Pharmacopoeia. 1988. British Pharmacopoeia II. H. M. Stationery Office: London, 704.
6. Dhanasekaran S, Suresh B, Sethuraman M, Rajan S, Dubey R. 1993. Antifertility of Ailanthus excelsa Linn, in female albino rats. Indian J Exp Biol 31: 384-385.
7. Fisher J. 1985. Drugs and chemicals that produce diabetes. Trends Pharmacol Sci 6: 72-75.
8. Gomes MB, Lucchetti MR, Goncalvez MFR, Gazzolla H, Dimetz T, Matos H. 1997. Influence of first morning urine volume, fasting blood glucose and glycosylated hemoglobin on first morning urinary albumin concentration. Brazil J Med Biol Res 30: 191-196.
9. Grover JK, Yadav S, Vats V. 2002. Medicinal plants of India with antidiabetic potential. J Ethnopharmacol 81: 81-100.
10. Hermann LS, Schersten B, Bitzen PO, Kjellstromt T, Lindgarde F, Melandev A. 1994. Therapeutic comparison of metformin and sulfonylurea, alone and various mechanisms. Diabetes Care 17: 1100-1109.
11. Hukkeri VI, Jaiprakash B, Lavhale MS, Karadi RV, Kuppast IJ. 2002. Hepatoprotective activity of Ailanthus excelsa Roxb. Leaf extract on experimental liver damage in rats. Indian J Pharm Educ 37: 105-106.
12. Joshi BC, Pandey A, Chaurasia L, Pal M, Sharma RP, Khare A. 2003. Antifungal activity of the stem bark of Ailanthus excelsa. Fitoterapia 74: 689-691.
13. Junod A, Lambert AE, Stauffacher W, Renold AE. 1969. Diabetogenic action of streptozotocin: relationship of dose to metabolic response. J Clin Invest 48: 2129-2139.
14. Kapoor SK, Ahmad PI, Zaman A. 1971. Chemical constituents of Ailanthus excelsa. Phytochemistry 10: 3333-3335.
15. Kim HY, Moon BH, Lee HJ, Choi DH. 2004. Flavonol glycosides from the leaves of Eucommia ulmoides O. with gycation inhibitory activity. J Ethnopharmacol 93: 227-230.
16. Korec R, Heinz Sensch K, Zoukas T. 2000. Effects of the neoflavonoid coutareagenin, one of the antidiabetic active substances of Hintonia latiflora, on streptozotocin-induced diabetes mellitus in rats. Arzneimittelforschung 50: 122-128.
17. Loizzo MR, Said A, Tundis R et al. 2007. Inhibition of angiotensin converting enzyme (ACE) by flavonoids isolated from Ailanthus excelsa (Roxb) (Simaroubaceae). Phytother Res 21: 32-36.
18. Marles RJ, Farnsworth NR. 1995. Antidiabetic plants and their active constituents. Phytomedicine 2: 137-189.
19. Mathiesen ER, Ronn B, Storm B, Foght H, Deckert T. 1994. The natural course of microalbuminuria in insulin-dependent diabetes: a 10-year prospective study. Diabetic Med 12: 482-487.
20. Nojima H, Kimura I, Chen FJ et al. 1998. Antihyperglycemic effects of N-containing sugars from Xanthocercis zambesiaca, Morus bombycis, Aglaonema trubii and Castanosperrmin australe in streptozotocin- diabetic mice. J Nat Prod 61: 397-400.
21. O'Brien RM, Granner DK. 1996. Regulation of gene expression by insulin. Physiol Rev 76: 1109-1161.
22. Ogura M, Cordell GA, Kinghorn AD, Farnsworth NR. 1977. Potential anticancer agents VI. Constituents of Ailanthus excelsa (Simaroubaceae). Lloydia 40: 579-584.
23. Shrimali M, Jain DC, Darokar MP, Sharma RP. 2001. Antibacterial activity of Ailanthus excelsa (Roxb). Phytother Res 15: 165-166.
24. WHO Expert Committee on Diabetes Mellitus. 1980. Diabetes Mellitus Second Report. Technical Report Series 646. World Health Organization: Geneva.
25. Zarzuelo A, Jimenez I, Gamez MJ et al. 1996. Effects of luteolin 5-O-beta-rutenoside in streptozotocin-induced diabetic rats. Life Sci 58: 2311-2316.